Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
Novo Nordisk A/S (NVO) Receives FDA Approval For Saxenda® For The Treatment Of Obesity 12/24/2014 6:07:42 AM
Actavis (ACT) and Adamas Pharmaceuticals (ADMS) Announce FDA Approval of Namzaric™, a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride 12/24/2014 6:40:53 AM
FDA Approves Novo Nordisk A/S (NVO)'s Weight Management Drug Saxenda 12/24/2014 6:06:34 AM
Actavis (ACT), Adamas Pharmaceuticals (ADMS) Win FDA Approval for Alzheimer's Drug Namzaric 12/24/2014 6:39:42 AM
Bristol-Myers Squibb Company (BMY) Receives Accelerated Approval Of Opdivo (Nivolumab) From The FDA 12/23/2014 6:10:58 AM
AbbVie (ABBV) Receives Health Canada Approval Of HOLKIRA™ PAK For The Treatment Of Chronic Genotype 1 Hepatitis C 12/23/2014 7:49:07 AM
Galderma Laboratories Receives FDA Approval Of Novel Treatment Option For Rosacea Patients 12/23/2014 9:09:47 AM
FDA Grants Accelerated Approval for Bristol-Myers Squibb Company (BMY)'s Skin Cancer Drug Opdivo 12/23/2014 6:10:02 AM
AstraZeneca PLC (AZN) Grabs Accelerated FDA Approval for Lynparza 12/22/2014 6:26:45 AM
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)’s GRANIX® (Tbo-Filgrastim) Injection For Self-Administration 12/23/2014 8:56:16 AM
AbbVie (ABBV) Receives U.S. FDA Approval Of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) For The Treatment Of Chronic Genotype 1 Hepatitis C 12/22/2014 5:54:40 AM
Biocryst Pharmaceuticals (BCRX)'s RAPIVAB™ (Peramivir Injection) Receives FDA Approval For The Treatment Of Acute Uncomplicated Influenza 12/22/2014 6:15:01 AM
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014 7:40:56 AM
AstraZeneca PLC (AZN) Release: LYNPARZA™ Approved By The FDA For The Treatment Of Advanced Ovarian Cancer In Patients With Germline BRCA-Mutations 12/22/2014 6:27:47 AM
LYNPARZA™ (Olaparib) Approved For The Treatment Of Advanced Relapsed Ovarian Cancer In Patients With Germline BRCA Mutations, Available Exclusively At Biologics, Inc. (NC) 12/22/2014 11:24:01 AM
1234567
//-->